Melinta Therapeutics

Company Listings from SPi: Melinta Therapeutics

You are here: Home >> SPi Company Listings >> Melinta Therapeutics

 

Melinta Therapeutics

Website:
http://

Search for other references to "melinta" on SPi News

Latest Melinta Therapeutics News

Melinta Therapeutics Names David Gill as Chairman and Announces CEO Succession Plan MORRISTOWN, N.J., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of nove...... 12:31 GMT Friday 9th August 2019

Melinta Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update MORRISTOWN, N.J., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company developing and commercializing novel antibiotics to trea...... 12:30 GMT Friday 9th August 2019

Melinta Therapeutics Announces Rescheduling of Second Quarter 2019 Financial Results Reporting MORRISTOWN, N.J., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of nove...... 22:04 GMT Tuesday 6th August 2019

Melinta Therapeutics Announces Preliminary Second Quarter 2019 Financial Results and Provides Corporate Update MORRISTOWN, N.J., July 16, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of nove...... 12:30 GMT Tuesday 16th July 2019

Melinta Therapeutics Announces U.S. FDA Acceptance of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Treatment of Community-Acquired Bacterial Pneumonia MORRISTOWN, N.J., June 19, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of nove...... 12:30 GMT Wednesday 19th June 2019

Melinta Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update MORRISTOWN, N.J., May 09, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company, developing and commercializing novel antibiotics to trea...... 21:00 GMT Thursday 9th May 2019

Melinta Therapeutics to Present at Making a Difference in Infectious Diseases (MAD-ID) 2019 Annual Meeting MORRISTOWN, N.J., May 07, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel...... 12:30 GMT Tuesday 7th May 2019

Melinta Therapeutics to Report First Quarter 2019 Financial Results on May 9, 2019 MORRISTOWN, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel...... 21:30 GMT Thursday 2nd May 2019

Melinta Therapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results MORRISTOWN, N.J., March 13, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company, developing and commercializing novel antibiotics to t...... 20:00 GMT Wednesday 13th March 2019

Melinta Therapeutics to Report Fourth Quarter and Year-End 2018 Financial Results on March 13, 2019 MORRISTOWN, N.J., March 05, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of nov...... 13:00 GMT Tuesday 5th March 2019

Buy Melinta Therapeutics
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us